Item 2. Unregistered Sales of Equity Securities
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
 
(a)
Unregistered Sales of Equity Securities
 
There were no securities of the Company sold by the Company during the quarter ended March 25, 2022, which were not registered under the Securities Act of 1933, in reliance upon an exemption from registration provided by Section 4 (2) of the Act.
 
(b)
Use of Proceeds
 
Not applicable.
 
(c)
Issuer Purchases of Equity Securities
 
27
 
 
Issuer Purchases of Equity Securities
 
Period
(a) Total Number of Shares Purchased
(b) Average Price Paid per Share
(c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
(d) Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
 
 
 
 
 
 
January 1 – January 28, 2022
 
0
NA
0
315,000
 
 
 
 
 
 
January 29 – February 25, 2022
 
0
NA
0
315,000
 
 
 
 
 
 
February 26 – March 25, 2022
 
0
NA
0
315,000
 
 
 
 
 
 
Total
 
0
NA
0
315,000
 
Under authorizations granted by the Board of Directors on February 1, 2008 and July 27, 2012, the Company was authorized to purchase 500,000 shares of its common stock.  This authorization has no expiration, and as of March 25, 2022, 315,000 may yet be purchased under these authorizations. The Company did not purchase any shares of its common stock pursuant to these authorizations during the quarter ended March 25, 2022.
 
The discussion of limitations upon the payment of dividends as a result of the Credit Agreement between the Company and BMO Harris Bank, N.A., as discussed in Part I, Item 2, "Management's Discussion and Analysis " under the heading "Financial Condition, Liquidity and Capital Resources," is incorporated herein by reference.
 
Item 3.
Defaults Upon Senior Securities
 
None.
 
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.